Pharmacological characterization of cardiac histamine receptors: sensitivity to H1-receptor antagonists.
D000818:Animals; D001011:Aorta; D001283:Atrioventricular Node / Q000502:physiology; D002744:Chlorpheniramine / Q000494:pharmacology; D003326:Coronary Circulation / Q000187:drug effects; D003501:Cyclizine / Q000494:pharmacology; D004155:Diphenhydramine / Q000494:pharmacology; D004305:Dose-Response Relationship, Drug; D004562:Electrocardiography; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects*; D006327:Heart Block / Q000139:chemically induced; D006339:Heart Rate / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D006632:Histamine / Q000008:administration & dosage / Q000494:pharmacology; D006634:Histamine H1 Antagonists / Q000494:pharmacology*; D066298:In Vitro Techniques; D007269:Injections, Intra-Arterial; D008297:Male; D010477:Perfusion; D011398:Promethazine / Q000494:pharmacology; D011955:Receptors, Drug / Q000187:drug effects*; D013268:Stimulation, Chemical; D014309:Tripelennamine / Q000494:pharmacology
D006634:Histamine H1 Antagonists; D011955:Receptors, Drug; D014309:Tripelennamine; D002744:Chlorpheniramine; D006632:Histamine; D004155:Diphenhydramine; D011398:Promethazine; D003501:Cyclizine